Drug discovery assay to screen for compounds
OwnerXavier SALVATELLA GIRALT, Mateusz BIESAGA +1inventors
InventorsXavier SALVATELLA GIRALT, Mateusz BIESAGA, Marta FRIGOLÉ VIVAS
Life of this patent
Estimating the term…
Abstract
The present invention provides a drug discovery assay to screen for compounds capable of modulating condensates based on the ability of the said compounds to shift the condensation propensity of a studied target, preferably an intrinsically disordered protein.
Claims12
A drug discovery assay, preferably a cell-free assay, to screen for compounds capable of shifting the critical temperature (Tc) at which a studied target, preferably an intrinsically disordered protein, forms condensates, the assay comprising:
- a. combining a test compound and a composition comprising the target prior to forming condensates;
- b. causing the formation of the target condensate in the presence of the test compound by a gradual and controlled increase of the temperature of the solution of a), wherein such gradual and controlled increase of the temperature of the solution of a) is performed at any speed selected from any value from 0.5 to 5° C. degrees/minute, more preferably from 0.8 to 2° C. degrees/minute;
- c. measuring the solution of a) by any spectroscopy-based measurement, preferably by measuring the absorbance, while performing the gradual and controlled increase of the temperature according to step b), so as determining whether the test compound shifts the critical temperature of reference at which the target forms the condensates, wherein the critical temperature of reference at which the target forms the condensates is understood as the temperature in which the target forms the condensates without the presence of the test compound;
- and
- selecting the test compound as a compound capable of shifting the condensation propensity of a studied target if the test compound significantly shifts the critical temperature of reference at which the target forms the condensates, or if the percentage of shift caused by the test compound in comparison to a reference shift caused by a reference compound is significantly greater, preferably greater than at least two or three standard deviations from the mean of activity values of the reference compound, preferably greater than 20%, 25%, 30%, 35% or 40% of the shift caused by the reference compound.
A drug discovery assay, preferably a cell-free assay, to screen for compounds capable of shifting the critical time value (tc) at which a studied target, preferably an intrinsically disordered protein, forms condensates, the assay comprising:
- a. combining a test compound and a composition comprising the target prior to forming condensates;
- b. causing the formation of the target condensate in the presence of the test compound by a gradual and controlled increase of the temperature of the solution of a), wherein such gradual and controlled increase of the temperature of the solution of a) is performed at any speed selected from any value from 0.5 to 5° C. degrees/minute, more preferably from 0.8 to 2° C. degrees/minute;
- c. measuring the solution of a) by any spectroscopy-based measurement, preferably by measuring the absorbance, while performing the gradual and controlled increase of the temperature according to step b), so as determining whether the test compound shifts the tc value of reference at which the target forms the condensates, wherein the tc value of reference is the time between the beginning of the gradual and controlled increase of the temperature of the solution of a) and the onset of condensation in conditions where the target forms the condensates without the presence of the test compound;
- and
- selecting the test compound as a compound capable of shifting the condensation propensity of a studied target if the test compound significantly shifts the tc value of reference at which the target forms the condensates or if the percentage of shift caused by the test compound in comparison to a reference shift caused by a reference compound is significantly greater, preferably greater than at least two or three standard deviations from the mean of activity values of the reference compound, preferably greater than 20%, 25%, 30%, 35% or 40% of the shift caused by the reference compound;
- wherein critical time value (tc) is understood as the time at which the onset of the condensation is observed, measured from the moment when the temperature starts to be ramped up (from the moment when the gradual and controlled increase of the temperature of the solution of a) starts).
The assay of any of the precedent claims, further comprising labelling the target in order to visualize the target condensate, such as with a radioactive label, a colorimetric label, or a fluorescent label.
The assay of any of the precedent claims, wherein the composition comprises two or more targets.
The assay of any of the precedent claims, wherein the amount of the test compound/s is determined by mass spectrometry, liquid chromatography, and/or ultraviolet-visible spectrophotometry.
Dependencies are inferred from the claim text.